Published in J Am Acad Dermatol on September 01, 2000
Abnormal mitoferrin-1 expression in patients with erythropoietic protoporphyria. Exp Hematol (2011) 1.01
Erythropoietic protoporphyria without skin symptoms-you do not always see what they feel. Eur J Pediatr (2007) 0.77
Level of expression of the nonmutant Ferrochelatase allele is a determinant of biochemical phenotype in a mouse model of erythropoietic protoporphyria. Gene Regul Syst Bio (2008) 0.76
Severe radiation therapy-related soft tissue toxicity in a patient with porphyria cutanea tarda: a literature review. Head Neck (2010) 0.75
A case of bilateral scarring of the cheeks in a child. J Cutan Aesthet Surg (2010) 0.75
Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders. Clin Pharmacokinet (2017) 0.75
The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A (1968) 6.96
Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem (1969) 5.35
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell (1999) 5.01
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med (1988) 4.67
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med (2001) 4.50
Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest (1982) 3.29
A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A (2001) 2.88
Erythropoietin, aluminium, and anaemia in patients on haemodialysis. Lancet (1990) 2.35
The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin. J Lab Clin Med (1970) 2.32
Rapid immunochemical detection of fecal occult blood by use of a latex-agglutination test. Clin Chem (1988) 2.03
Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med (1970) 1.88
Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Med (1987) 1.80
Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (1997) 1.74
Enzymatic degradation of heme. Oxygenative cleavage requiring cytochrome P-450. Biochemistry (1972) 1.71
Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol (1997) 1.66
Reduced nicotinamide-adenine dinucleotide phosphate dependent biliverdin reductase: partial purification and characterization. Biochemistry (1970) 1.53
Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J Intern Med (1989) 1.44
The enzymatic degradation of hemoglobin to bile pigments by macrophages. J Exp Med (1971) 1.43
Deletion 3q27----3qter in an infant with mild dysmorphism, parietal meningocele, and neonatal miliaria rubra-like lesions. Hum Genet (1989) 1.43
Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog (1996) 1.41
Inducible heme oxygenase in the kidney: a model for the homeostatic control of hemoglobin catabolism. J Clin Invest (1971) 1.40
Angiosarcoma. A rare secondary malignancy after breast cancer treatment. Eur J Dermatol (1999) 1.39
Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis. Clin Nephrol (1995) 1.39
Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer (1999) 1.38
Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol (1997) 1.34
Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol (1997) 1.26
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia (1998) 1.25
Reduced amyloid-A-degrading activity in serum in amyloidosis associated with rheumatoid arthritis. Br Med J (Clin Res Ed) (1982) 1.20
Immunoturbidimetry of albumin and immunoglobulin G in urine. Clin Chem (1982) 1.13
Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. J Invest Dermatol (1999) 1.12
Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum (1989) 1.12
Ichthyosis hystrix (Curth-Macklin). Light and electron microscopic studies performed before and after etretinate treatment. Arch Dermatol (1984) 1.11
Letter: Negative complement-fixation tests as an immunopathological finding. Lancet (1974) 1.10
Tumor necrosis factor in children with malignancies. Cancer Res (1990) 1.09
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis. Kidney Int (2000) 1.09
Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population. Am J Hum Genet (1997) 1.07
Release of TGF-beta 1 and VEGF in tears following photorefractive keratectomy. Curr Eye Res (1997) 1.07
Acute phase response in dairy cows with experimentally induced Escherichia coli mastitis. Acta Vet Scand (1999) 1.07
Interstitial collagenase is expressed by keratinocytes that are actively involved in reepithelialization in blistering skin disease. J Invest Dermatol (1995) 1.05
The enzymatic conversion of hemoglobin to bilirubin. Trans Assoc Am Physicians (1969) 1.04
Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes (1986) 1.04
Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease. Liver (1984) 1.03
Human tear fluid PDGF-BB, TNF-alpha and TGF-beta1 vs corneal haze and regeneration of corneal epithelium and subbasal nerve plexus after PRK. Exp Eye Res (2001) 1.03
Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase. Eur J Clin Invest (1989) 1.03
Atrophic gastritis in Sjögren's syndrome. Morphologic, biochemical, and immunologic findings. Arthritis Rheum (1985) 1.03
Changes in haem synthesis associated with occupational exposure to organic and inorganic sulphides. Clin Sci (Lond) (1983) 1.03
Increased release of tumour necrosis factor-alpha in human tear fluid after excimer laser induced corneal wound. Br J Ophthalmol (1997) 1.01
Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms. Eur J Clin Invest (1992) 1.00
Mechanism of reduced amyloid-A-degrading activity in serum of patients with secondary amyloidosis. Lancet (1982) 1.00
Haem arginate in the treatment of acute hepatic porphyrias. Br Med J (Clin Res Ed) (1986) 1.00
Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J (Clin Res Ed) (1983) 0.99
Nodules on the legs. A clinical, histological and immunohistological study of 82 patients representing different types of nodular panniculitis. Acta Derm Venereol (1977) 0.99
Diagnostic application of monoclonal antibodies to intermediate filaments. Ann N Y Acad Sci (1985) 0.99
Sclerosing lymphangitis of the penis. Br J Vener Dis (1972) 0.99
The benign fibrohistiocytic tumours of the skin. Acta Derm Venereol Suppl (Stockh) (1970) 0.99
Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol Dial Transplant (1997) 0.99
Trinitrotoluene-induced effects on rat heme metabolism. Exp Mol Pathol (1984) 0.98
Neurological manifestations of acute intermittent porphyria. Cell Mol Biol (Noisy-le-grand) (2009) 0.97
Glomerular IgA deposits in patients with celiac disease. Clin Nephrol (1990) 0.97
Serum phospholipase A2, immunoreactive trypsin, and trypsin inhibitors during human acute pancreatitis. Scand J Gastroenterol (1982) 0.96
Pityriasis rubra pilaris. A clinico-pathological study with a special reference to autoradiography and histocompatibility antigens. Dermatologica (1976) 0.96
The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China. Eur Respir J (2002) 0.96
Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection. Clin Nephrol (1984) 0.96
Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis (1982) 0.95
Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol (1999) 0.95
Clinical and morphological correlations for transglutaminase 1 gene mutations in autosomal recessive congenital ichthyosis. Eur J Hum Genet (1999) 0.94
Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes. Diabetologia (1999) 0.94
Early rise in serum concentration of transferrin receptor induced by recombinant human erythropoietin in very-low-birth-weight infants. Pediatr Res (1994) 0.94
An intestinal receptor for heme. Scand J Haematol (1979) 0.93
Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis. Kidney Int (1995) 0.93
Inverse T(2) contrast at 1.5 Tesla between gray matter and white matter in the occipital lobe of normal adult human brain. Magn Reson Med (2001) 0.92
New observations on the fine structure of lamellar ichthyosis and the effect of treatment with etretinate. Am J Dermatopathol (1983) 0.92
Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus. Rheumatol Int (1992) 0.92
Integrins in human cells and tumors. Cell Differ Dev (1990) 0.92
Analysis of false-positive BTA STAT test results in patients followed up for bladder cancer. Urology (2001) 0.91
Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1993) 0.91
Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion. Laryngoscope (2000) 0.91
Heme arginate treatment for myelodysplastic syndromes. Leuk Res (1988) 0.91
Platelet-derived growth factor-BB (PDGF-BB) in tear fluid: a potential modulator of corneal wound healing following photorefractive keratectomy. Curr Eye Res (1997) 0.91
Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia (1995) 0.91
Heme synthesis in sideroblastic anaemias. Scand J Haematol Suppl (1986) 0.90
Mesangial glomerulonephritis as an extra-articular manifestation of rheumatoid arthritis. Br J Rheumatol (1997) 0.90
Elevated seizure threshold and impaired spatial learning in transgenic mice with putrescine overproduction in the brain. Eur J Neurosci (1993) 0.90
High pleural fluid hyaluronan concentrations in rheumatoid arthritis. Eur Respir J (1999) 0.90
Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care (2000) 0.90
Cytoskeleton and pericellular matrix organization of pure adult human keratinocytes cultured from suction-blister roof epidermis. J Cell Sci (1982) 0.90
Adhesion molecules and urinary tumor necrosis factor-alpha in idiopathic membranous glomerulonephritis. Kidney Int (1998) 0.89
Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys (1995) 0.89
Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator. Ann Med (1991) 0.89
Light and electron microscopy of psoriatic skin before and during retinoid (Ro 10-9359) and retinoid-PUVA treatment. J Cutan Pathol (1982) 0.89
Ocular findings in four siblings with pseudoxanthoma elasticum. Acta Ophthalmol (Copenh) (1983) 0.89
Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions. Exp Dermatol (2001) 0.89
Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant (1994) 0.89
Naevus elasticus (elastoma juvenile Weidman) and naevus collagenicus lumbosacralis in Pringle's disease. Dermatologica (1968) 0.89
Diffuse soft tissue calcifications (calcinosis cutis) in a patient with discoid lupus erythematosus. Clin Exp Dermatol (1988) 0.88
Renal growth and function 11-28 years after treatment of Wilms' tumour. Eur J Pediatr (1991) 0.88
Proton electrochemical potential of the inner mitochondrial membrane in isolated perfused rat hearts, as measured by exogenous probes. Biochim Biophys Acta (1983) 0.88
Effects of psychological stress on plasma interleukins-1 beta and 6, C-reactive protein, tumour necrosis factor alpha, anti-diuretic hormone and serum cortisol. Scand J Clin Lab Invest (1993) 0.87
DNA antibodies with and without complement-binding ability. Rheumatol Int (1984) 0.87